Article Data

  • Views 443
  • Dowloads 127

Original Research

Open Access

Primary peritoneal cancer: study of 14 cases and comparison with epithelial ovarian cancer

  • T. Fukuda1,*,
  • K. Imai1
  • M. Yamauchi1
  • M. Teramae1
  • Y. Hashiguchi1
  • T. Ichimura1
  • T. Yasui1
  • T. Sumi1

1Department of Obstetrics and Gynecology, Osaka City University Graduate School of Medicine, Abeno-ku, Osaka , Japan

DOI: 10.12892/ejgo2573.2015 Vol.36,Issue 1,February 2015 pp.49-53

Published: 10 February 2015

*Corresponding Author(s): T. Fukuda E-mail: takeshif@med.osaka-cu.ac.jp

Abstract

Purpose of investigation: Primary peritoneal carcinoma (PPC) is histologically similar to ovarian serous carcinoma, but its biochemical features remain obscure. The authors investigated and compared clinical findings, treatments, and outcomes of patients with PPS and those with epithelial ovarian cancer (EOC) patients. Materials and Methods: The authors retrospectively reviewed data from 14 patients with PPC and 219 patients with EOC treated at the present hospital from January 2005 to December 2012, including demographic data, pathologic findings, treatments, and outcomes. Results: Patients with PPC were significantly older (62.6 ± 8.4 years) than those with EOC (56.3 ± 11.3 years) (p = 0.045). There was no significant difference in serum CA-125 levels. The five-year survival rates did not differ significantly between patients with PPC (61.1%) and those with EOC (60.3%; p = 0.78); nor between patients with PPC and those with Stage III serous EOC (43.8%; p = 0.40). Conclusions: Treatment strategies for EOC applied to PPC apparently led to similar survival patterns among the two patient groups. Cytoreductive surgery combined with pre/postoperative platinum-containing chemotherapy may be effective for PPC patients.

Keywords

Primary peritoneal cancer; Epithelial ovarian cancer; Cytoreductive surgery; Platinum-containing chemotherapy.

Cite and Share

T. Fukuda,K. Imai,M. Yamauchi,M. Teramae,Y. Hashiguchi,T. Ichimura,T. Yasui,T. Sumi. Primary peritoneal cancer: study of 14 cases and comparison with epithelial ovarian cancer. European Journal of Gynaecological Oncology. 2015. 36(1);49-53.

References

[1] Swerdlow M.: “Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report”. Am. J. Obstet. Gynecol., 1959, 77, 197.

[2] August C.Z., Murad T.M., Newton M.: “Multiple focal extraovarian serous carcinoma”. Int. J. Gynecol. Pathol., 1985, 4, 11.

[3] Bhuyan P., Mahapatra S., Mahapatra S., Sethy S., Parida P., Satpathy S.: “Extraovarian primary peritoneal papillary serous carcinoma”. Arch. Gynecol. Obstet., 2010, 281, 561.

[4] Truong L.D., Maccato M.L., Awalt H., Cagle P.T., Schwartz M.R., Kaplan A.L.: “Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases”. Hum. Pathol., 1990, 21, 99.

[5] Resta L., Maiorano E., Zito F.A., Faggiano F., Loizzi P., Ferreri R., Borraccino V., Conte R., Lucisano F.: “Multifocal extraovarian serous carcinoma. A histochemical and immunohistochemical study”. Eur. J. Gynecol. Oncol., 1988, 9, 474.

[6]. Raju U., Fine G., Greenawald K.A., Ohorodnik J.M.: “Primary papillary serous neoplasia of the peritoneum: a clinicopathologic and ultrastructural study of eight cases”. Hum. Pathol., 1989, 20, 426.

[7] Tobacman J.K., Greene M.H., Tucker M.A., Costa J., Kase R., Fraumeni J.F. Jr.: “Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families”. Lancet, 1982, 2, 795.

[8] Eltabbakh G.H., Piver M.S., Natarajan N., Mettlin C.J.: “Epidemiologic differences between women with extraovarian primary peritoneal carcinoma and women with epithelial ovarian cancer”. Obstet. Gynecol., 1998, 91, 254.

[9] Kowalski L.D., Kanbour A.I., Price F.V., Finkelstein S.D., Christopherson W.A., Seski J.C., Naus G.J., Burnham J.A., Kanbour-Shakir A., Edwards R.P.: “A case-matched molecular comparison of extraovarian versus primary ovarian adenocarcinoma”. Cancer, 1997, 79, 1578.

[10] Chen L.M., Yamada S.D., Fu Y.S., Baldwin R.L., Karlan B.Y.: “Molecular similarities between primary peritoneal and primary ovarian carcinomas”. Int. J. Gynecol. Cancer., 2003, 13, 749.

[11] Bloss J.D., Liao S.Y., Buller R.E., Manetta A., Berman M.L., McMeekin S., Bloss L.P., Di Saia P.J.: “Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary”. Gynecol. Oncol., 1993, 50, 347.

[12] Killackey M.A., Davis A.R.: “Papillary serous carcinoma of the peritoneal surface: matched-case comparison with papillary serous ovarian carcinoma”. Gynecol. Oncol., 1993, 51, 171.

[13] Shah I.A., Jayram L., Gani O.S., Fox I.S., Stanley T.M.: “Papillary serous carcinoma of the peritoneum in a man: a case report”. Cancer, 1998, 82, 860.

[14] Dalrymple J.C., Bannatyne P., Russell P., Solomon H.J., Tattersall M.H., Atkinson K., et al.: “Extraovarian peritoneal serous papillary carcinoma. A clinicopathologic study of 31 cases”. Cancer, 1989, 64, 110.

[15] Fromm G.L., Gershenson D.M., Silva E.G.: “Papillary serous carcinoma of the peritoneum”. Obstet. Gynecol., 1990, 75, 89.

[16] Jordan S.J., Green A.C., Whiteman D.C., Moore S.P., Bain C.J., Gertig D.M., Webb P.M.: “Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis”. Int. J. Cancer, 2008, 122, 1598.

[17] Fowler J.M., Nieberg R.K., Schooler T.A., Berek J.S.: “Peritoneal adenocarcinoma (serous) of Müllerian type: a subgroup of women presenting with peritoneal carcinomatosis”. Int. J. Gynecol. Cancer, 1994, 4, 43.

[18] Gooneratne S., Sassone M., Blaustein A., Talerman A.: “Serous surface papillary carcinoma of the ovary: a clinicopathologic study of 16 cases”. Int. J. Gynecol. Pathol., 1982, 1, 258.

[19] Rothacker D., Möbius G.: “Varieties of serous surface papillary carcinoma of the peritoneum in northern Germany: a thirty-year autopsy study”. Int. J. Gynecol. Pathol., 1995, 14, 310.

[20] Ransom D.T., Patel S.R., Keeney G.L., Malkasian G.D., Edmonson J.H.: “Papillary serous carcinoma of the peritoneum. A review of 33 cases treated with platin-based chemotherapy”. Cancer, 1990, 66, 1091.

[21] Eltabbakh G.H., Werness B.A., Piver S., Blumenson L.E.: “Prognostic factors in extraovarian primary peritoneal carcinoma”. Gynecol. Oncol., 1998, 71, 230.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top